Ticlopidine is a P2Y\(_{12}\) receptor antagonist, inhibiting platelet aggregation by blocking ADP receptor activation.
This prevents fibrinogen binding to GPIIb/IIIa receptors, reducing thrombus formation.
It was historically used for stroke prevention, but newer drugs like clopidogrel have largely replaced it due to safety concerns.